Journavx: Uses, Dosage, Side Effects, Warnings - Drugs.com
1 day ago · Journavx (suzetrigine) is a new non-opioid pain-relieving tablet used to treat short-term (acute) moderate to severe pain. Journavx is a sodium channel blocker that relieves pain by blocking pain-sensing nerves around the body from transmitting pain messages to the spinal cord and brain. Since it does not affect the brain, it is not expected to ...
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
1 day ago · The safety profile of Journavx is primarily based on data from the pooled, double-blind, placebo- and active-controlled trials in 874 participants with moderate to severe acute pain following ...
What to Know About Journavx, the Non-Opioid Pain Medication …
1 day ago · The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years. By Cecelia Smith-Schoenwalder Jan. 31, 2025
FDA Approves Journavx - Drugs.com
Journavx is a prescription medicine used to treat adults with moderate-to-severe short term (acute) pain. It is not known if Journavx is safe and effective in children. IMPORTANT SAFETY INFORMATION. Patients should not take Journavx if they take certain medicines that are strong inhibitors of an enzyme called CYP3A. Patients should ask their ...
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
1 day ago · For the first time in 25 years, the U.S. Food and Drug Administration has approved a new type of painkiller. Suzetrigine, sold as Journavx, is administered twice daily in 50-milligram oral tablets ...
New FDA-Approved Painkiller Is a Safer Alternative to Opioids
23 hours ago · Journavx is approved to treat moderate-to-severe acute pain in adults, such as pain following surgery or injury. Suzetrigine, the active ingredient in Journavx, belongs to a class of medications called NaV1.8 pain signal inhibitors. The drug works by blocking pain signals in peripheral nerves before they reach the brain.
FDA Approves Journavx, First New Non-Opioid Pain Pill in Decades
1 day ago · FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgery or injury, the Associated Press reported.
FDA approves new non-opioid pain medication Journavx: What …
1 day ago · Journavx was found to help reduce pain by blocking pain signals in the peripheral nervous system before pain signals reach the brain. Reshma Kewalramani, CEO and president of Vertex, called the ...
FDA approves first new type of pain medication in 25 years
1 day ago · A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
1 day ago · The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...
- Some results have been removed